Oxothiazolidine Carboxylate Provides Protection against Hepatocellular Injury Seen after Porta Hepatis Occlusion (Pringle Maneuver) under Hypovolemic Conditions
The sensitivity of liver to warm ischemia has always been a concern for surgeons. To monitor the ischemia and/or reperfusion injury after the Pringle maneuver (occlusion of porta hepatis) in livers subjected to hemorrhage, blood pressure, blood pH, base deficit (BE), serum alanine aminotransferase (...
Gespeichert in:
Veröffentlicht in: | World journal of surgery 2003-04, Vol.27 (4), p.448-454 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 454 |
---|---|
container_issue | 4 |
container_start_page | 448 |
container_title | World journal of surgery |
container_volume | 27 |
creator | Özgüç, Halil Tokyay, Rifat Kahveci, Nevzat Serdar, Zehra Gur, Esma Surmen Korfali, Ender |
description | The sensitivity of liver to warm ischemia has always been a concern for surgeons. To monitor the ischemia and/or reperfusion injury after the Pringle maneuver (occlusion of porta hepatis) in livers subjected to hemorrhage, blood pressure, blood pH, base deficit (BE), serum alanine aminotransferase (ALT), serum and liver malondialdehyde (MDA), and liver glutathione (GSH) levels were measured. MDA is a by‐product of oxidant induced lipid peroxidation, and GSH is an endogenous antioxidant. The effect of lactated Ringer’s (LR) resuscitation with or without the addition of 2‐oxothiazolidine‐4‐carboxylate (OTC), a cysteine prodrug (enhancing glutathione production) on liver injury, if any, were investigated. Rats in the sham group (n = 8) and five other groups (n = 8) underwent femoral artery and vein catheterization and laparotomy. The hemorrhage group was bled 30% of their blood volume and the ischemia group underwent occlusion of the porta hepatis 30 minutes. The hemorrhage‐ischemia (HI), LR, and OTC groups underwent both hemorrhage and occlusion. The LR and OTC groups, 30 minutes after hemorrhage, received either LR resuscitation (equivalent to three times the shed blood) or LR resuscitation plus IV OTC (100 mg/kg before clamping and 100 mg/kg after de‐clamping). Porta hepatis occlusion in the presence of hypovolemia (HI group) caused an increase in serum ALT, plasma MDA, liver MDA, and base deficit and a decrease in blood pH levels. LR resuscitation lowered only MDA (plasma and liver) and base deficit but did not reduce ALT and increase blood pH. Although liver GSH did not change, OTC kept all parameters at control levels. OTC prevents the deleterious effects of total hepatic inflow occlusion under hypovolemic conditions, but this does not occur through enhancement liver glutathione production. OTC may protect the liver by accelerating hepatic glutathione turnover, but further studies are needed to explain its mechanism of action. |
doi_str_mv | 10.1007/s00268-002-6551-x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73131048</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73131048</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411X-51ced9bf8c54470bddb85067d59fb039c148129f5be9c661cc8a730d4b907edd3</originalsourceid><addsrcrecordid>eNqFkc-O0zAQxi0EYkvhAbggCwkEh4Cd2HFyA1VAFy1qpYLYm-XYk8WVG3ftpDQ8DY-KQyutxIXL59HoN388H0JPKXlDCRFvIyF5WWVJs5Jzmh3voRllRZ7lRV7cRzNSlCzFtLhAj2LcEkJFScqH6ILmJa9YTWfo9-ro-x9W_fLOGtsBXqjQ-OPoVA94HfzBGohT0IPure-wulG2iz1ewl71XoNzg1MBX3bbIYx4A5CQtoeA1z706oTZiFdauyFODV6tg-1uHOAvqoPhAOE1HjqTCpbj3h-8g53VeOE7Y6d58TF60CoX4cn5naNvHz98XSyzq9Wny8X7q0wzSq8zTjWYumkrzRkTpDGmqTgpheF125Ci1pRVNK9b3kCty5JqXSlREMOamggwppijl6e---BvB4i93Nk4fS9t6YcoRTojJaxK4PN_wK0fQpd2kzmta86KdPw5oidIBx9jgFbug92pMEpK5OSdPHknk8rJO3lMNc_OjYdmB-au4mxWAl6cARW1cm1QnbbxjmOi5ELwxL07cT-tg_H_k-X3z5vN3-QkKXVd_AH06LhX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219954332</pqid></control><display><type>article</type><title>Oxothiazolidine Carboxylate Provides Protection against Hepatocellular Injury Seen after Porta Hepatis Occlusion (Pringle Maneuver) under Hypovolemic Conditions</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Özgüç, Halil ; Tokyay, Rifat ; Kahveci, Nevzat ; Serdar, Zehra ; Gur, Esma Surmen ; Korfali, Ender</creator><creatorcontrib>Özgüç, Halil ; Tokyay, Rifat ; Kahveci, Nevzat ; Serdar, Zehra ; Gur, Esma Surmen ; Korfali, Ender</creatorcontrib><description>The sensitivity of liver to warm ischemia has always been a concern for surgeons. To monitor the ischemia and/or reperfusion injury after the Pringle maneuver (occlusion of porta hepatis) in livers subjected to hemorrhage, blood pressure, blood pH, base deficit (BE), serum alanine aminotransferase (ALT), serum and liver malondialdehyde (MDA), and liver glutathione (GSH) levels were measured. MDA is a by‐product of oxidant induced lipid peroxidation, and GSH is an endogenous antioxidant. The effect of lactated Ringer’s (LR) resuscitation with or without the addition of 2‐oxothiazolidine‐4‐carboxylate (OTC), a cysteine prodrug (enhancing glutathione production) on liver injury, if any, were investigated. Rats in the sham group (n = 8) and five other groups (n = 8) underwent femoral artery and vein catheterization and laparotomy. The hemorrhage group was bled 30% of their blood volume and the ischemia group underwent occlusion of the porta hepatis 30 minutes. The hemorrhage‐ischemia (HI), LR, and OTC groups underwent both hemorrhage and occlusion. The LR and OTC groups, 30 minutes after hemorrhage, received either LR resuscitation (equivalent to three times the shed blood) or LR resuscitation plus IV OTC (100 mg/kg before clamping and 100 mg/kg after de‐clamping). Porta hepatis occlusion in the presence of hypovolemia (HI group) caused an increase in serum ALT, plasma MDA, liver MDA, and base deficit and a decrease in blood pH levels. LR resuscitation lowered only MDA (plasma and liver) and base deficit but did not reduce ALT and increase blood pH. Although liver GSH did not change, OTC kept all parameters at control levels. OTC prevents the deleterious effects of total hepatic inflow occlusion under hypovolemic conditions, but this does not occur through enhancement liver glutathione production. OTC may protect the liver by accelerating hepatic glutathione turnover, but further studies are needed to explain its mechanism of action.</description><identifier>ISSN: 0364-2313</identifier><identifier>EISSN: 1432-2323</identifier><identifier>DOI: 10.1007/s00268-002-6551-x</identifier><identifier>PMID: 12658491</identifier><identifier>CODEN: WJSUDI</identifier><language>eng</language><publisher>New York: Springer‐Verlag</publisher><subject>Animals ; Base Deficit ; Biological and medical sciences ; Constriction ; Gastroenterology. Liver. Pancreas. Abdomen ; Hepatic Artery ; Hypovolemia - physiopathology ; Inflow Occlusion ; Lactate Ringer ; Liver - blood supply ; Liver - physiopathology ; Liver Glutathione ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; Models, Animal ; Other diseases. Semiology ; Portal Vein ; Pringle Maneuver ; Pyrrolidonecarboxylic Acid ; Rats ; Rats, Sprague-Dawley ; Reperfusion Injury - prevention & control ; Reperfusion Injury - therapy ; Thiazoles - therapeutic use ; Thiazolidines</subject><ispartof>World journal of surgery, 2003-04, Vol.27 (4), p.448-454</ispartof><rights>2003 International Society of Surgery</rights><rights>2003 INIST-CNRS</rights><rights>Copyright Springer-Verlag 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411X-51ced9bf8c54470bddb85067d59fb039c148129f5be9c661cc8a730d4b907edd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1007%2Fs00268-002-6551-x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1007%2Fs00268-002-6551-x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14765775$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12658491$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Özgüç, Halil</creatorcontrib><creatorcontrib>Tokyay, Rifat</creatorcontrib><creatorcontrib>Kahveci, Nevzat</creatorcontrib><creatorcontrib>Serdar, Zehra</creatorcontrib><creatorcontrib>Gur, Esma Surmen</creatorcontrib><creatorcontrib>Korfali, Ender</creatorcontrib><title>Oxothiazolidine Carboxylate Provides Protection against Hepatocellular Injury Seen after Porta Hepatis Occlusion (Pringle Maneuver) under Hypovolemic Conditions</title><title>World journal of surgery</title><addtitle>World J Surg</addtitle><description>The sensitivity of liver to warm ischemia has always been a concern for surgeons. To monitor the ischemia and/or reperfusion injury after the Pringle maneuver (occlusion of porta hepatis) in livers subjected to hemorrhage, blood pressure, blood pH, base deficit (BE), serum alanine aminotransferase (ALT), serum and liver malondialdehyde (MDA), and liver glutathione (GSH) levels were measured. MDA is a by‐product of oxidant induced lipid peroxidation, and GSH is an endogenous antioxidant. The effect of lactated Ringer’s (LR) resuscitation with or without the addition of 2‐oxothiazolidine‐4‐carboxylate (OTC), a cysteine prodrug (enhancing glutathione production) on liver injury, if any, were investigated. Rats in the sham group (n = 8) and five other groups (n = 8) underwent femoral artery and vein catheterization and laparotomy. The hemorrhage group was bled 30% of their blood volume and the ischemia group underwent occlusion of the porta hepatis 30 minutes. The hemorrhage‐ischemia (HI), LR, and OTC groups underwent both hemorrhage and occlusion. The LR and OTC groups, 30 minutes after hemorrhage, received either LR resuscitation (equivalent to three times the shed blood) or LR resuscitation plus IV OTC (100 mg/kg before clamping and 100 mg/kg after de‐clamping). Porta hepatis occlusion in the presence of hypovolemia (HI group) caused an increase in serum ALT, plasma MDA, liver MDA, and base deficit and a decrease in blood pH levels. LR resuscitation lowered only MDA (plasma and liver) and base deficit but did not reduce ALT and increase blood pH. Although liver GSH did not change, OTC kept all parameters at control levels. OTC prevents the deleterious effects of total hepatic inflow occlusion under hypovolemic conditions, but this does not occur through enhancement liver glutathione production. OTC may protect the liver by accelerating hepatic glutathione turnover, but further studies are needed to explain its mechanism of action.</description><subject>Animals</subject><subject>Base Deficit</subject><subject>Biological and medical sciences</subject><subject>Constriction</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Hepatic Artery</subject><subject>Hypovolemia - physiopathology</subject><subject>Inflow Occlusion</subject><subject>Lactate Ringer</subject><subject>Liver - blood supply</subject><subject>Liver - physiopathology</subject><subject>Liver Glutathione</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Models, Animal</subject><subject>Other diseases. Semiology</subject><subject>Portal Vein</subject><subject>Pringle Maneuver</subject><subject>Pyrrolidonecarboxylic Acid</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reperfusion Injury - prevention & control</subject><subject>Reperfusion Injury - therapy</subject><subject>Thiazoles - therapeutic use</subject><subject>Thiazolidines</subject><issn>0364-2313</issn><issn>1432-2323</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkc-O0zAQxi0EYkvhAbggCwkEh4Cd2HFyA1VAFy1qpYLYm-XYk8WVG3ftpDQ8DY-KQyutxIXL59HoN388H0JPKXlDCRFvIyF5WWVJs5Jzmh3voRllRZ7lRV7cRzNSlCzFtLhAj2LcEkJFScqH6ILmJa9YTWfo9-ro-x9W_fLOGtsBXqjQ-OPoVA94HfzBGohT0IPure-wulG2iz1ewl71XoNzg1MBX3bbIYx4A5CQtoeA1z706oTZiFdauyFODV6tg-1uHOAvqoPhAOE1HjqTCpbj3h-8g53VeOE7Y6d58TF60CoX4cn5naNvHz98XSyzq9Wny8X7q0wzSq8zTjWYumkrzRkTpDGmqTgpheF125Ci1pRVNK9b3kCty5JqXSlREMOamggwppijl6e---BvB4i93Nk4fS9t6YcoRTojJaxK4PN_wK0fQpd2kzmta86KdPw5oidIBx9jgFbug92pMEpK5OSdPHknk8rJO3lMNc_OjYdmB-au4mxWAl6cARW1cm1QnbbxjmOi5ELwxL07cT-tg_H_k-X3z5vN3-QkKXVd_AH06LhX</recordid><startdate>200304</startdate><enddate>200304</enddate><creator>Özgüç, Halil</creator><creator>Tokyay, Rifat</creator><creator>Kahveci, Nevzat</creator><creator>Serdar, Zehra</creator><creator>Gur, Esma Surmen</creator><creator>Korfali, Ender</creator><general>Springer‐Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>200304</creationdate><title>Oxothiazolidine Carboxylate Provides Protection against Hepatocellular Injury Seen after Porta Hepatis Occlusion (Pringle Maneuver) under Hypovolemic Conditions</title><author>Özgüç, Halil ; Tokyay, Rifat ; Kahveci, Nevzat ; Serdar, Zehra ; Gur, Esma Surmen ; Korfali, Ender</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411X-51ced9bf8c54470bddb85067d59fb039c148129f5be9c661cc8a730d4b907edd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Base Deficit</topic><topic>Biological and medical sciences</topic><topic>Constriction</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Hepatic Artery</topic><topic>Hypovolemia - physiopathology</topic><topic>Inflow Occlusion</topic><topic>Lactate Ringer</topic><topic>Liver - blood supply</topic><topic>Liver - physiopathology</topic><topic>Liver Glutathione</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Models, Animal</topic><topic>Other diseases. Semiology</topic><topic>Portal Vein</topic><topic>Pringle Maneuver</topic><topic>Pyrrolidonecarboxylic Acid</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reperfusion Injury - prevention & control</topic><topic>Reperfusion Injury - therapy</topic><topic>Thiazoles - therapeutic use</topic><topic>Thiazolidines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Özgüç, Halil</creatorcontrib><creatorcontrib>Tokyay, Rifat</creatorcontrib><creatorcontrib>Kahveci, Nevzat</creatorcontrib><creatorcontrib>Serdar, Zehra</creatorcontrib><creatorcontrib>Gur, Esma Surmen</creatorcontrib><creatorcontrib>Korfali, Ender</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>World journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Özgüç, Halil</au><au>Tokyay, Rifat</au><au>Kahveci, Nevzat</au><au>Serdar, Zehra</au><au>Gur, Esma Surmen</au><au>Korfali, Ender</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxothiazolidine Carboxylate Provides Protection against Hepatocellular Injury Seen after Porta Hepatis Occlusion (Pringle Maneuver) under Hypovolemic Conditions</atitle><jtitle>World journal of surgery</jtitle><addtitle>World J Surg</addtitle><date>2003-04</date><risdate>2003</risdate><volume>27</volume><issue>4</issue><spage>448</spage><epage>454</epage><pages>448-454</pages><issn>0364-2313</issn><eissn>1432-2323</eissn><coden>WJSUDI</coden><abstract>The sensitivity of liver to warm ischemia has always been a concern for surgeons. To monitor the ischemia and/or reperfusion injury after the Pringle maneuver (occlusion of porta hepatis) in livers subjected to hemorrhage, blood pressure, blood pH, base deficit (BE), serum alanine aminotransferase (ALT), serum and liver malondialdehyde (MDA), and liver glutathione (GSH) levels were measured. MDA is a by‐product of oxidant induced lipid peroxidation, and GSH is an endogenous antioxidant. The effect of lactated Ringer’s (LR) resuscitation with or without the addition of 2‐oxothiazolidine‐4‐carboxylate (OTC), a cysteine prodrug (enhancing glutathione production) on liver injury, if any, were investigated. Rats in the sham group (n = 8) and five other groups (n = 8) underwent femoral artery and vein catheterization and laparotomy. The hemorrhage group was bled 30% of their blood volume and the ischemia group underwent occlusion of the porta hepatis 30 minutes. The hemorrhage‐ischemia (HI), LR, and OTC groups underwent both hemorrhage and occlusion. The LR and OTC groups, 30 minutes after hemorrhage, received either LR resuscitation (equivalent to three times the shed blood) or LR resuscitation plus IV OTC (100 mg/kg before clamping and 100 mg/kg after de‐clamping). Porta hepatis occlusion in the presence of hypovolemia (HI group) caused an increase in serum ALT, plasma MDA, liver MDA, and base deficit and a decrease in blood pH levels. LR resuscitation lowered only MDA (plasma and liver) and base deficit but did not reduce ALT and increase blood pH. Although liver GSH did not change, OTC kept all parameters at control levels. OTC prevents the deleterious effects of total hepatic inflow occlusion under hypovolemic conditions, but this does not occur through enhancement liver glutathione production. OTC may protect the liver by accelerating hepatic glutathione turnover, but further studies are needed to explain its mechanism of action.</abstract><cop>New York</cop><pub>Springer‐Verlag</pub><pmid>12658491</pmid><doi>10.1007/s00268-002-6551-x</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0364-2313 |
ispartof | World journal of surgery, 2003-04, Vol.27 (4), p.448-454 |
issn | 0364-2313 1432-2323 |
language | eng |
recordid | cdi_proquest_miscellaneous_73131048 |
source | MEDLINE; Springer Nature - Complete Springer Journals; Wiley Online Library Journals Frontfile Complete |
subjects | Animals Base Deficit Biological and medical sciences Constriction Gastroenterology. Liver. Pancreas. Abdomen Hepatic Artery Hypovolemia - physiopathology Inflow Occlusion Lactate Ringer Liver - blood supply Liver - physiopathology Liver Glutathione Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Models, Animal Other diseases. Semiology Portal Vein Pringle Maneuver Pyrrolidonecarboxylic Acid Rats Rats, Sprague-Dawley Reperfusion Injury - prevention & control Reperfusion Injury - therapy Thiazoles - therapeutic use Thiazolidines |
title | Oxothiazolidine Carboxylate Provides Protection against Hepatocellular Injury Seen after Porta Hepatis Occlusion (Pringle Maneuver) under Hypovolemic Conditions |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A08%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxothiazolidine%20Carboxylate%20Provides%20Protection%20against%20Hepatocellular%20Injury%20Seen%20after%20Porta%20Hepatis%20Occlusion%20(Pringle%20Maneuver)%20under%20Hypovolemic%20Conditions&rft.jtitle=World%20journal%20of%20surgery&rft.au=%C3%96zg%C3%BC%C3%A7,%20Halil&rft.date=2003-04&rft.volume=27&rft.issue=4&rft.spage=448&rft.epage=454&rft.pages=448-454&rft.issn=0364-2313&rft.eissn=1432-2323&rft.coden=WJSUDI&rft_id=info:doi/10.1007/s00268-002-6551-x&rft_dat=%3Cproquest_cross%3E73131048%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=219954332&rft_id=info:pmid/12658491&rfr_iscdi=true |